chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Moderna Booster. Within 24 hours noticed swelling on his left side, in the armpit area. The swelling is quite significant. Only a little painful when trying to feel for lymph nodes.
As with the first one I had soreness on the arm. I moved my arm around. 24 hours later exactly I had a fever, achy, exhausted. 101.8 fever, this was on a Friday. Sunday, fever went down to 100. Monday, I was extremely fatigued for 2 weeks, I could barely walk. I was managing to go to work but couldn't do anything and they sent me to the work clinic. It would take all my energy to do anything. The nurse told me that it's my body's prolonged reaction to the vaccine. The following week I went to my Doctor and she recommended that I get Covid so she had me get tested. This lasted for about 3-4 weeks, then I was able to get my energy back. This also happened after my 3rd dose.
After initial vaccination had some localized redness and swelling. Six months after vaccination started noticing a indentation where the vaccine was given. She came into our office almost a year from administration with subq tissue atrophy where the vaccine was administered.
chronic allergic problem; constant bouts of sneezing; runny nose; I get red balls all over my body; I can't take care of my pets anymore; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A male patient received bnt162b2 (COMIRNATY) (Batch/Lot number: unknown) as dose 1, single for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: DRUG HYPERSENSITIVITY (non-serious), outcome "unknown", described as "chronic allergic problem"; SNEEZING (non-serious), outcome "unknown", described as "constant bouts of sneezing"; RHINORRHOEA (non-serious), outcome "unknown", described as "runny nose"; URTICARIA (non-serious), outcome "unknown", described as "I get red balls all over my body"; LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES (non-serious), outcome "unknown", described as "I can't take care of my pets anymore".  Additional information: He never had allergies in his life. Patient was much better before He put this poison in his body.  No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
After receiving vaccine patient became flushed and shortness of breath. EMS was called by their arrival shortness of breath was starting to subside. About 15 minutes.
my arm swelled up; had a huge knot in it; I couldnt lift or use my arm for about a week and a half; I couldnt lift or use my arm for about a week and a half; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP). The reporter is the patient.  A 66-year-old female patient received pneumococcal 20-val conj vac (dipht CRM197 protein) (PREVNAR 20), as dose number unknown, single (Batch/Lot number: unknown) for immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: PERIPHERAL SWELLING (non-serious), outcome "unknown", described as "my arm swelled up"; NODULE (non-serious), outcome "unknown", described as "had a huge knot in it"; VACCINATION SITE MOVEMENT IMPAIRMENT (non-serious), MUSCULOSKELETAL DISORDER (non-serious), outcome "unknown" and all described as "I couldnt lift or use my arm for about a week and a half".  Additional information: Patient had that vaccine and had a bad experience with it her arm swelled up and had a huge knot in it and she couldnt lift or use her arm for about a week and a half. No more vaccines for her. open ended question: Thinking of the video you just saw, please enter anything you felt, thought, or were reminded of while viewing it. Everything is acceptable. There are no right or wrong answers, no silly or dumb feelings. Don't worry about spelling, punctuation, or grammar.   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021; This spontaneous case was reported by an other health care professional and describes the occurrence of PRODUCT TEMPERATURE EXCURSION ISSUE (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 13-Feb-2021 at 10:49 AM, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 13-Feb-2021 at 10:49 AM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). In 2021, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021). At the time of the report, PRODUCT TEMPERATURE EXCURSION ISSUE (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) and POOR QUALITY PRODUCT ADMINISTERED (patients where administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   On 13-Feb-2021, excursion time was 9 AM, temp was 32, total doses given for the day was 152, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 09-Feb-2021, vial was moved to clinic on 13-Jan-2021. 30 vial was moved to clinic. Vaccine BUD date was 10-Mar-2021.  Vial was stored on cooler 2, on 13-Feb-2021, excursion duration At 8 AM: Not provided, 9 AM: 32, 10 AM: 39, 11 AM:42, 12 AM: 41, 1PM: 40, 2 PM : 40, 3 PM: 40, 4 PM: 41 and 5 PM : Not provided.  Vials only punctured right before administration  Concomitant products were not provided.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks on 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.    Treatment medications were not reported.
This case was reported by a pharmacist via call center representative and described the occurrence of pain in arm in a 63-year-old female patient who received SHINGRIX for prophylaxis. In August 2018, the patient received the 1st dose of SHINGRIX (intramuscular). On an unknown date, less than a year after receiving SHINGRIX, the patient experienced pain in arm and bone pain. On an unknown date, the outcome of the pain in arm and bone pain were recovered/resolved. It was unknown if the reporter considered the pain in arm and bone pain to be related to SHINGRIX. Additional details were provided as follows: The reporter was a pharmacist and she was also the patient. She received the 1st dose of SHINGRIX in the beginning of August 2018 in the left arm. She had intense pain in her left arm that last for a few weeks. The patient stated that her entire left forearm was in pain and it almost felt like the pain was in the bone as well. The reporter did not gave consent to follow-up.
This spontaneous report was received from a 60 years old male consumer reporting on himself with no pertinent medical history, any history of any eye problems and no drug reactions or allergies, who on 23-APR-2012, was vaccinated with one dose vial of ZOSTAVAX (dose, route and lot number not reported). No other co-suspects were reported. No concomitant medications were reported. The consumer reported that on 26-APR-2012, he had started to have an adverse experience. The consumer's unspecified eye had started to hurt him. The consumer went to his ophthalmologist and he diagnosed him with herpes keratitis. Then, on 07-MAY-2012, the ophthalmologist confirmed that the patient had recurrent herpes simplex virus. Then from May 14th to today, 15-OCT-2012, the consumer had not have any outbreaks of this eye trouble. ZIRGAN was given as a treatment for the experience. No lab diagnostics studies were performed. On 14-MAY-2012, the patient recovered from the experience. The relatedness for patient was diagnosed with herpes keratitis was unknown for ZOSTAVAX. Additional information has been requested.
Within 24 hours post vax, the pt developed local symptoms consisting of pain and pruritus lasting 1-3 days. Then he developed systemic symptoms-muscle aches, joint pain, headache, neck pain, abdominal pain, and nausea.
Per family, patient reported to have been experiencing fatigue for several days after receiving Covid vaccine.  On 6/15/21, patient's significant other discovered patient in bed, not breathing, with ashen appearance, uncertain how long it had been since patient was last breathing.  EMS was contacted, CPR was given and patient was transferred to Emergency Department at the hospital.  Diagnosis of Cardiologist is cardiac arrest, NSTEMI (suspects type 2).  Per cardiologist, patient appears to exhibit cardiomyopathy, etiology difficult to ascertain (patient's family/acquaintances have endorsed periodic use by patient of anabolic steroids in the past, making it more difficult to rule out source of cardiomyopathy. ). Physicians involved are reporting this case in the event that this may be a case of vaccine-induced myocarditis, although no diagnosis as such has been made.
01/05/22 presents to ED for "fever and COVID +" "fatigued" "dizzy". PMHx of "PMH addison's disease and hypothyroidism"
On awakening, experienced dizziness, headache. No fever. Symptoms lasted 2 days.
Within 5 minutes of receiving the vaccine, patient passed out face first in the store.  He woke up almost immediately after hitting the floor.  Said he was fine when he woke up, only felt a little dizzy before he passed out.
Pt received dose and went and set down, within a minute he reported severe nausea. He began to sweat profusely . Pulse was erratic. He started to complain of chest pain and trouble breathing. We laid him down and administered epinephrine 0.3 and he responded immediately. He was doing well by the time the ambulance arrived.
Starting evening of 10/22/22, chills, fatigue, low motivation/energy.  Night of 10/23 - slight diarrhea in bed.  Start to wear diapers in bed/out of house.  Still very tired, no appetite at all.  10/27 - took temp...100.2.  Over the next few weeks, temps have gone from 99 thru 101.4.  Tylenol at times for temp, headaches.  Rash at groin, both sides.
A half inch needle syringe was used instead of a one inch for administration of the Pfizer COVID 10 vaccine.
Pt. given 0.5 ml of COVID pfizer vaccine instead of 0.3 ml.  No treatment necessary, monitored for adverse effects.  CDC was called for guidance.
Site: Pain at Injection Site-Mild, Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: PATIENT STATES SHE HAS A REGULAR HISTORY OF PASSING OUT AFTER RECEIVING VACCINATIONS - THIS IS NOT A NEW REACTION FOR HER. SHE IMMEDIATELY REGAINED CONSCIOUSNESS AFTER ABOUT 10 SECONDS. SHE STATED SHE FELT FINE RIGHT BEFORE LEAVING
Patient Reports that he has a significantly sore arm after the immunizations. He then developed tingling on his left extremities. He also reports numbness, weakness, a change in his voice and a slight droop
This spontaneous prospective pregnancy report was received from a 19 year old female patient regarding herself. The patient had no relevant medical history. Her relevant past history was unknown. On 23-FEB-2013, the patient was vaccinated with a dose of (Oka/Merck) VARIVAX (lot #, expiry, dose, route were unknown). The patient did not take any concomitant medication. On an unknown date, the patient experienced exposure in utero. On an unknown date in 2013, a week or so after receiving (Oka/Merck) VARIVAX she had a positive urine pregnancy test. No other relevant laboratory testing was performed. The LMP (last menstrual period) and EDD (estimated date of delivery) were not known. The pregnancy outcome was pending. The outcome of exposure in utero was unknown. Follow-up information has been received from a registered nurse on 06-NOV-2014. The reporter stated that the patient was never seen in the office for her pregnancy. The patient had an appointment schedule for 08-APR-2013. The appointment was canceled with no reason given, and not rescheduled. The pregnancy outcome was unknown. The outcome of exposure in utero was recovered/resolved on an unknown date, approximately in 2013. Additional information is not expected, because there was no more information available.
This spontaneous report received from a consumer concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, vaccination site not given, batch number: Unknown) dose was not reported, administered on 19-MAR-2021 for prophylactic vaccination. The batch number was not reported and has been requested No concomitant medications were reported. On MAR-2021, the subject experienced fever. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from fever on MAR-2021. This report was non-serious.
I had my flu shot in my left arm on 10/1/2013 and had what I thought was normal aching for a couple of weeks, which then progressed to my lower deltoid region. I asked if people were complaining about the flu shot because my soreness was not going away (She said no or not more than usual). My left arm aching began to get much worse in mid-October. I had been doing some crocheting in early to mid October and I thought this may have played a part in my left arm pain, so I quit doing it. Even though I quit crocheting, the pain got worse in my left arm/shoulder and then progressed to my right shoulder too. This caused me to wake-up multiple times during the night because of the pain. I have had multiple tests done and was diagnosed as having Parsonage-Turner syndrome.
arm swelled again, with two little balls, both hot and red; could hardly sleep at night; arm swelled again, with two little balls, both hot and red; pain in the arm; felt groggy; the area near the injection was a little swollen and hard; headache for a day; the area near the injection was a little swollen and hard; This spontaneous case was reported by a physician and describes the occurrence of PAIN IN EXTREMITY (pain in the arm), INSOMNIA (could hardly sleep at night), SOMNOLENCE (felt groggy), VACCINATION SITE WARMTH (arm swelled again, with two little balls, both hot and red) and VACCINATION SITE INDURATION (the area near the injection was a little swollen and hard) in a 42-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012A21A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No medical history was provided by the reporter.  Concomitant products included IRON and METOPROLOL for an unknown indication.    On 09-Mar-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 09-Mar-2021, the patient experienced PAIN IN EXTREMITY (pain in the arm), SOMNOLENCE (felt groggy), VACCINATION SITE INDURATION (the area near the injection was a little swollen and hard), HEADACHE (headache for a day) and VACCINATION SITE SWELLING (the area near the injection was a little swollen and hard). On 16-Mar-2021, the patient experienced INSOMNIA (could hardly sleep at night), VACCINATION SITE WARMTH (arm swelled again, with two little balls, both hot and red) and VACCINATION SITE ERYTHEMA (arm swelled again, with two little balls, both hot and red). The patient was treated with IBUPROFEN for Adverse event, at an unspecified dose and frequency. On 14-Mar-2021, PAIN IN EXTREMITY (pain in the arm), SOMNOLENCE (felt groggy), VACCINATION SITE INDURATION (the area near the injection was a little swollen and hard) and HEADACHE (headache for a day) had resolved. At the time of the report, INSOMNIA (could hardly sleep at night) outcome was unknown and VACCINATION SITE WARMTH (arm swelled again, with two little balls, both hot and red), VACCINATION SITE SWELLING (the area near the injection was a little swollen and hard) and VACCINATION SITE ERYTHEMA (arm swelled again, with two little balls, both hot and red) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   On 16-Mar-2021, the patient's arm swelled again, with two little balls, one at the injection site and the other below, both hot and red. She could hardly sleep at night, and now there was only one big, hot, red ball and their arm was very swollen in that area.
Patient received peds doseage of Hep B vaccine instead of the adult Hep B. No reaction or advers event occurred. Patient was notified to come in and receive the Adult Hep B per County Health Department.
This spontaneous report as received from a licensed practical nurse refers to a 2 month old patient of unknown gender. On 11-NOV-2014, the patient was vaccinated with a dose of VAQTA, 0.5 ml, intramuscular (lot # and expiration date were not provided). On 11-NOV-2014, the patient received VAQTA at the age of two months. No adverse effect was reported. It was unknown if the patient sought medical attention. At the time of the report, the patient's status was unkown. Additional information is not expected. There was no authorization to contact physician.
Vaccine was placed in fridge on 12/1/21 and administered on 1/6/22.
Narrative:  Medical Decision Making Developed COVID with receiving COVID vaccine Patient's oxygen saturations remained in the high 90s throughout his evaluation. Patient exhibits no increased work of breathing. Given patient's BMI greater than 25 and history of hypertension he qualifies for monoclonal antibody treatment. I discussed monoclonal antibody treatment with the patient and he is agreeable to receiving it at this time. Patient provided with infusion and monitored for 1 hour at conclusion of infusion. Patient demonstrates no evidence of adverse reaction.
Pt still experiencing pain radiating down arm from injection site. Injection was 1 week ago. Pt went to PCP & the flu shot was blamed.
The next day after vaccination the patient started having vaginal bleeding that lasted for 30 days.  She was even bleeding out clots of blood
expired dose administered to patients; This spontaneous case was reported by a nurse and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) in a 35-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 031H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 04-Jan-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 04-Jan-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients). On 04-Jan-2022, EXPIRED PRODUCT ADMINISTERED (expired dose administered to patients) had resolved.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication of the patient was not reported.  No treatment information was provided by the reporter.   Number of doses/vials were 63 doses, 3-4 vials; date the vial was initially stored in the refrigerator was on 01-Dec-2021 and the vial did not undergo any temperature excursions.  It was reported by the reporter that, some patients had reported flu-like symptoms after receiving the vaccination, but she did not have details on that.
11/20/08, client called to inform County Health Division that after receiving INFLUENZA vaccine at 3:30 pm on 11/19/08. At about 6:30 pm, developed watery eyes, wheezing difficulty breathing and was driven to hosp. ER by a friend. At ER was started on IV fluids, given antihistamine steroids and a breathing treatment. Client was discharged home at 8 pm with a prescription for a steroid x 4 days and prn antihistamine. Client recovered by 11/20/08. Returning to work that AM. Had never had a flu shot previously. Tetanus vacc. 4 mons prior - no reactions.
arm hurt; chills; fatigue; headache; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (arm hurt), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     Concurrent medical conditions included Asthma (Inhaler daily for asthma), Blood pressure high and Obesity. Concomitant products included MONTELUKAST for Allergy, FEXOFENADINE HYDROCHLORIDE (ALLEGRA) and LABETALOL for an unknown indication.    On 12-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced PAIN IN EXTREMITY (arm hurt), CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache). At the time of the report, PAIN IN EXTREMITY (arm hurt) had not resolved and CHILLS (chills), FATIGUE (fatigue) and HEADACHE (headache) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       treatment to the events not provided.
pt recv vax & 5 days p/vax pt devel a classic presentation of rt facial Bell's palsy;In the next two weeks pt had nearly 100% resolved sx;